Caxton Associates (New York)’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-21,379
Closed -$396K 516
2022
Q4
$396K Sell
21,379
-4,809
-18% -$82.4K 0.03% 285
2022
Q3
$412K Buy
+26,188
New +$588K 0.05% 276
2021
Q2
Sell
-2,664
Closed -$239K 485
2021
Q1
$239K Buy
+2,664
New +$293K 0.02% 335

Other funds holding CRNC

Caxton Associates (New York)'s CRNC Position: Q1 2023 in Review

Caxton Associates (New York) sold out of Cerence (CRNC) in Q1 2023, closing a stake of 21,379 shares — an estimated $396K sold.

Caxton Associates (New York) first reported a position in CRNC in Q1 2021 and held it in 3 quarters. The position peaked at $412K in Q3 2022. 228 funds tracked by Wall St. Rank hold CRNC as of Q1 2023.

  • Caxton Associates (New York) reported no remaining Cerence position as of Q1 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 21,379 Cerence shares in Q1 2023, an estimated $396K.
  • Caxton Associates (New York) first reported a position in Cerence in Q1 2021 and held it in 3 quarters.
  • Caxton Associates (New York)'s Cerence position peaked at $412K in Q3 2022.
  • 228 funds tracked by Wall St. Rank held Cerence as of Q1 2023.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.